3Oudemans - van Straaten HM. Citrate anticoagulation for continu?ous renal replacement therapy in the critically ill[J]. Blood Purif, 2010,29(2) :191 -196. 被引量：1
4Kutsogiannis DJ, Gibney RT, Stollery D, et al. Regional citrate versus systemic hepsrin anticoagulation for continuous renal re?placement in critically ill patients[J]. Kidney Int, 2005,67 ( 6) : 2361 -2367. 被引量：1
5Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on con?tinuous venovenous haemofiltration , a prospective randomized mul?ticentre trial[J]. Nephrol Dial Transplant, 2011, 26 (1) :232 -239. 被引量：1
6Kamath PS, Kim WR. The model for end - stage liver disease (MELD)[J]. Hepatology, 2007,45 (3) :797 - 805. 被引量：1
7Link A, Klingele M, Speer T, et al. Total - to - ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients[J]. Crit Care, 2012,16(3) :R97. 被引量：1
8Llach F, Weidmann P, Reinhart R, et al. Effect of acute and long - standing hypocalcemia on blood pressure and plasma renin activity in man[J]. J Clin Endocrinol Metab, 1974,38 (5) : 841-847. 被引量：1
9Saner FH, Treckmann JW, Geis A, et al. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requi?ring post - operative renal replacement therapy[J]. Nephrol Dial Transplant, 2012,27(4) :1651-1657. 被引量：1
10Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. hepsrin for anticoagulation in continuous venovenous hemofiltration , a prospective randomized studyj J}, Intensive Care Med, 2004,30(2) :260 -265. 被引量：1
